drugset / Trial / NCT05234580
Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
PA9159 is a highly potent novel corticosteroid. The purpose of this study is to evaluate the safety, efficacy and characteristics of population pharmacokinetics of multiple dosing of PA9159 Nasal Spray in patients with seasonal allergic rhinitis.
Timeline
- Start
- 2022-04-15
- Primary completion
- 2022-10-10
- Completion
- 2022-12-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PA9159 | Small molecule | 10 ug | Intranasal |
| Subject | PA9159 | Small molecule | 20 ug | Intranasal |
| Subject | PA9159 | Small molecule | 40 ug | Intranasal |